Prevention of PNX and Haemorrhagic Complications in Diagnostic Percutaneous Lung Biopsy Using the MIPP-Kit Device

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

February 27, 2020

Study Completion Date

March 27, 2020

Conditions
Complications in Diagnostic Percutaneous Lung Biopsy Procedures
Interventions
DEVICE

Percutaneous Lung Biopsy

Patients will undergo the usual biopsy procedure with a fine needle inserted through a larger guide needle, under CT guidance; at the end of the biopsy, the MIPP-Kit will be introduced through the same guide needle. The guide needle and the MIPP Kit will be retracted together slowly, whilst injecting BioGlue in appropriate amounts along the whole track, from the lesion to the skin.

Trial Locations (3)

37126

Azienda Ospedaliera Universitaria Integrata Verona, Verona

70124

Istituto Tumori Bari Giovanni Paolo II, Bari

00168

Fondazione Policlinico Universitario A. Gemelli, Roma

Sponsors
All Listed Sponsors
lead

BetaGlue Technologies spa

INDUSTRY